Cargando…

A retrospective in‐depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management

Continuous glucose monitoring (CGM) systems have great potential for real‐time assessment of glycemic variation in patients with hepatic glycogen storage disease (GSD). However, detailed descriptions and in‐depth analysis of CGM data from hepatic GSD patients during interventions are scarce. This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Peeks, Fabian, Hoogeveen, Irene J., Feldbrugge, R. Lude, Burghard, Rob, de Boer, Foekje, Fokkert‐Wilts, Marieke J., van der Klauw, Melanie M., Oosterveer, Maaike H., Derks, Terry G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519135/
https://www.ncbi.nlm.nih.gov/pubmed/33834518
http://dx.doi.org/10.1002/jimd.12383
Descripción
Sumario:Continuous glucose monitoring (CGM) systems have great potential for real‐time assessment of glycemic variation in patients with hepatic glycogen storage disease (GSD). However, detailed descriptions and in‐depth analysis of CGM data from hepatic GSD patients during interventions are scarce. This is a retrospective in‐depth analysis of CGM parameters, acquired in a continuous, real‐time fashion describing glucose management in 15 individual GSD patients. CGM subsets are obtained both in‐hospital and at home, upon nocturnal dietary intervention (n = 1), starch loads (n = 11) and treatment of GSD Ib patients with empagliflozin (n = 3). Descriptive CGM parameters, and parameters reflecting glycemic variation and glycemic control are considered useful CGM outcome parameters. Furthermore, the combination of first and second order derivatives, cumulative sum and Fourier analysis identified both subtle and sudden changes in glucose management; hence, aiding assessment of dietary and medical interventions. CGM data interpolation for nocturnal intervals reduced confounding by physical activity and diet. Based on these analyses, we conclude that in‐depth CGM analysis can be a powerful tool to assess glucose management and optimize treatment in individual hepatic GSD patients.